Tempus AI, Inc. - 8-K Filing

Tempus AI enters into a fifth amendment to its Master Services Agreement with AstraZeneca, establishing a $200 million financial commitment through 2031. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TEM

Read the full article at SEC EDGAR

Part of the story Ainos, Inc. - 8-K Filing (3 articles)

More Regulatory news